asa guidelines for glp 1 drugs GLP-1 agonists and anesthesia risk: Assessment of gastric content using ultrasound New therapeutic agents for type

Because GLP-1 receptor agonists are believed to be metabolized in various areas throughout the body and not specifically in the liver, 35 no significant variations were expected within any of the groups

doi:10.1124/pr.115.011395 39

In a study of 18 people with AD, exenatide treatment for 18 months was associated with lower plasma-sourced, neuron-derived extracellular vesicle (NDEV) A42 levels, although all other fluid biomarkers remained unchanged (62)

Another patient on one of these drugs for weight loss told me that alcohol had lost its pull after years of failed attempts to quit

Intensive lifestyle intervention has been shown to generate weight loss leading to remission of T2D (Lean, 2018

But GLP-1s could make drinking less less of a choice and more of a physiological baseline